glycomics

The mass spectrometry instrument maker will provide A*Star's Bioprocessing Technology Institute with expertise and access to a Synapt G2-S instrument.

NEW YORK (GenomeWeb) – Certain Agilent Technologies mass spectrometers and liquid chromatography instruments now support Premier Biosoft's SimGlycan glycomics software as part of a deal announced today.

NEW YORK (GenomeWeb News) – Emory University will use a $5.5 million grant from the National Institute of General Medical Sciences to create a new National Center for Functional Glycomics that will house a range of glycosciences research, Emory said today.

NEW YORK (GenomeWeb News) – Building on an existing relationship, Agilent Technologies and Chungnam National University in South Korea today announced new initiatives in the area of glycomics.

NEW YORK (GenomeWeb News) – Ezose Sciences today said that it has signed an agreement to collaborate with Kyowa Hakko Kirin on glycomics studies using Ezose's GlycanMap platform.

NEW YORK (GenomeWeb News) – Ezose Sciences today said that it will collaborate with Fast Forward, a subsidiary of the National Multiple Sclerosis Society, to discover biomarkers that may help diagnose multiple sclerosis, improve disease management, and help guide development of new MS medicines.

NEW YORK (GenomeWeb News) – Van Andel Institute and Emory University researchers will use a $2.3 million grant from the National Cancer Institute to fund an effort to develop new biomarker tools that can aid in the early diagnosis of pancreatic cancer.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Ezose Sciences today said that it has signed an agreement with Merck to conduct a diabetes biomarker discovery research project.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Bruker and Chungnam National University in South Korea announced today a collaboration to develop MALDI-TOF-based methodologies for the analysis of glycans.

Pages

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.